A clinical trial was carried out on the functional Stride ingredient. This randomized, double-blind, placebo-controlled study included a study group given the functional Stride ingredient, and a group given a placebo. The groups were sex-matched and recruited from the ages of 40 to 75 years, and neither the subjects nor the investigators knew which treatments were given to which subjects.
At baseline, 30, 60, and 90 days of taking the supplements, the study subjects completed the Western Ontario and McMaster Universities Osteo- Arthritis Index (WOMAC) for scoring joint function, stiffness, and comfort. This scale was used because it is a validated, high performance instrument for evaluative research in joint health with multiple validations of its construct validity, reliability, responsiveness, and relative efficiency.
Results showed that the Stride functional compound improved WOMAC scores of joint function, stiffness, and comfort across the board, significantly outperforming the placebo after only 30 days in all of these measures.
Use of Stride’s functional compound is the clear answer for improved joint function, mobility and comfort. The level and credibility of the study methods, combined with the astounding significance of results across the board establish Stride as a product that stands out above all the rest.